VANCOUVER, BC — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage Canadian pharmaceutical development company, is pleased to announce positive topline data… Read More
The quest to repair severed spinal cords has brought together the brightest minds from across institutions and disciplines in a spinal cord injury research program, Mend the Gap, that was… Read More
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status. The Elecsys HCV Duo immunoassay enables significantly earlier diagnosis… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announces Michael Woudenberg has been… Read More
The 2022-2026 contract continues a 20 year-long relationship with the Government of Canada for pandemic and seasonal influenza vaccines Up to 80 million doses of pandemic influenza vaccine to be supplied to… Read More
